JCM | Free Full-Text | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Biomedicines | Free Full-Text | DNA Methylation Signatures of Response to Conventional Synthetic and Biologic Disease-Modifying Antirheumatic Drugs ( DMARDs) in Rheumatoid Arthritis
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Biomolecules | Free Full-Text | Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics
Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends - ScienceDirect
Disease-modifying antirheumatic drugs - ScienceDirect
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan | springermedizin.de
Real-world treatment patterns of rheumatoid arthritis in Brazil: analysis of DATASUS national administrative claims data for pharmacoepidemiology studies (2010–2020) | Scientific Reports
Small Molecule DMARD Therapy and Its Position in RA Treatment | IntechOpen
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Biologic DMARDs and targeted synthetic DMARDs approved for the... | Download Scientific Diagram
Rheumatoid arthritis: Finding the right treatment can take years, Part 2 - Prime Therapeutics LLC
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
Patient disposition. DMARD, disease-modifying antirheumatic drug; mITT,... | Download Scientific Diagram
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea | Rheumatology and Therapy
The Safety of Antirheumatic Drugs (11.02.2022)
Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
:max_bytes(150000):strip_icc()/dmards-5200573_final-d7a3435040364245b453126ef7ee6572.jpg "DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,")
DMARDs for Rheumatoid Arthritis: Types, Uses, Dosages,
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
